Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06627270 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 6, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Mar 11, 2025 to Jul 22, 2025v8
  2. Re-verified, no change to tracked fieldsv7
  3. Eligibility criteria expanded, about 10 wordsv6
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 2025 to Mar 11, 2025
    • Site details revised
    v5
  5. Start date: May 1, 2025 to Jul 2025v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Feb 1, 2025 to May 1, 2025v3
  2. Start date: Dec 1, 2024 to Feb 1, 2025
    • Primary endpoint revised
    • Secondary endpoints revised (3)
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this phase II single arm clinical study is to evaluate the effect of antibiotics (metronidazole) and oral chlorhexidine (CHX) in reducing the bacteria load within tumors of patients undergoing surgery for oral cancer.
Trial Details
NCT Number NCT06627270
Lead Sponsor Case Comprehensive Cancer Center
Conditions
(from sponsor)		 Oral Squamous Cell Carcinoma, Oral Cancer, Head and Neck Cancer, Head and Neck Carcinoma
Related terms Head and Neck Neoplasms, Mouth Neoplasms, Squamous Cell Carcinoma of Head and Neck
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov